Collegium Pharmaceutical Inc (COLL)
Cost of Revenue
$323.12M
TTM · Period ending: · USD
COLL Cost of Revenue
Latest reported$323.12Mperiod ending
Latest reported$323.12Mperiod ending
COLL TTM Cost of Revenue ($0.00 → $323.12M)
TTM cost of revenue
High-resolution chart · PNG
COLL cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 323,121,000 | |
| 313,151,000 | |
| 317,310,000 | |
| 323,900,000 | |
| 306,217,000 | |
| 281,071,000 | |
| 254,105,000 | |
| 225,559,000 | |
| 219,450,000 | |
| 226,700,000 | |
| 240,598,000 | |
| 265,314,000 | |
| 277,090,000 | |
| 286,555,000 | |
| 254,445,000 | |
| 203,309,000 | |
| 167,865,000 | |
| 129,383,000 | |
| 126,251,000 | |
| 129,535,000 | |
| 127,788,000 | |
| 124,779,000 | |
| 130,180,000 | |
| 147,289,000 | |
| 163,060,000 | |
| 182,020,000 | |
| 193,660,000 | |
| 174,298,000 | |
| 173,551,000 | |
| 171,735,000 | |
| 165,677,000 | |
| 137,045,000 | |
| 91,591,000 | |
| 45,330,000 | |
| 2,595,000 | |
| 1,685,000 | |
| 1,161,000 | |
| 584,000 | |
| 213,000 | |
| 29,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |